Global CRISPR/Cas9 Tools Market Opportunity & Insights Report 2017

DUBLIN, Dec. 13, 2017 /PRNewswire/ --

The "Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017" report has been added to Research and Markets' offering.

Since its inception, CRISPR has gained strong traction from the global research community because of its huge potential in diverse applications. Considering CRISPR's disruptive and game-changing applications, a number of large and small participants have invested in this domain. Along the same line, CRISPR has witnessed a multi-fold uptake in funding from the National Institutes of Health (NIH) and other government agencies. As a result, these investments have led to significant growth in new product and application development, thereby creating new market segments and revenue growth opportunities for existing companies and new entrants.

In 2017, the CRISPR/Cas9 tools market opportunity will likely be about $1.8 to $2 billion. The therapeutics and agriculture segments will contribute the most revenue potential. The market is currently highly fragmented, with a handful of global participants and a large number of application-focused participants operating in their respective segments. Competition in the therapeutics and agriculture domains is highly concentrated, and most market and technology developments have been focused around a few companies. Even large pharmaceutical companies have partnered with these existing participants to source innovation and to support their product development using CRISPR. With the ongoing patent war between the University of California and Broad Institute, this situation will likely remain the same. It is expected that large pharmaceutical companies will only commit direct investments in this segment after understanding the final outcome of the ongoing patent cases.

The objective of this research study is to consider and analyze all these market developments and present a realistic market landscape. This research publication covers insights on existing and emerging growth opportunities in the CRISPR/Cas9 tools market. The study covers qualitative market insights on various market segments and sub-segments, including agriculture, human therapeutics, research tools, and drug discovery activities. The report identifies existing gaps in product and service offerings of key participants across segments, disruptive technologies, and key market and technology trends. The research study further delves into the market's competitive landscape and patent licensing landscape analysis.

Key Topics Covered:

1. Executive Summary

• Key Findings
• Key Questions This Study Will Answer
• Market Definitions and Other Gene-editing Options
• Scope and Segmentation-CRISPR/Cas9 Tools Market
• Market Background and Overview

2. Growth Drivers and Opportunities

• Key Market Drivers
• Growth Drivers Explained
• Key Market Restraints
• Restraints Explained
• CRISPR/Cas9 Research Funding Growth
• CRISPR/Cas9 Tools Market Potential

3. Growth Opportunities

• Growth Opportunity 1-CRISPR Therapeutics Development
• CRISPR Therapeutics-Collaboration and Partnerships
• Competitive Ecosystem of the CRISPR Therapeutics Segment
• Potential Opportunities
• Growth Opportunity 2-Animal and Disease Model Development
• Product Portfolio Benchmarking and Gap Analysis
• Key Market Opportunities
• Growth Opportunity 3-CRISPR Research and Design Tools
• Product Portfolio Benchmarking and Gap Analysis
• Key Market Opportunities
• Growth Opportunity 4-Drug Compound and Target Screening
• Growth Opportunity 5-Agriculture and Nutritional Healthcare Products
• CRISPR in Agriculture-Current Status and Future Applications

4. Growth Opportunities Matrix

• Growth Opportunity Matrix-Key Opportunities and Business Impact

5. Key Market Trends and Impact Analysis

• Market Trends
• Market Impact of Top Trends

6. Competitive Analysis

• Competitive Environment
• Key Market Companies
• Companies to Action
• Competitor List

7. Patient Licensing Landscape

• Patent Licensing-Current Landscape

8. Potential Game-changing Disruptive Technologies

• Potential Game-changing Disruptive Technologies

9. Strategic Imperatives

For more information about this report visit https://www.researchandmarkets.com/research/rpbqw9/global?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets